Status:
COMPLETED
Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)
Lead Sponsor:
Organon and Co
Conditions:
Seasonal Allergic Rhinitis
Eligibility:
All Genders
15-85 years
Phase:
PHASE3
Brief Summary
This study will evaluate the ability of oral montelukast/loratadine to improve the signs and symptoms of seasonal allergic rhinitis compared with loratadine alone, montelukast alone and placebo.
Eligibility Criteria
Inclusion
- Patient has a documented history of seasonal allergic rhinitis symptoms that flare up during the study season
- Patient is a nonsmoker
- Patient is in good general health
Exclusion
- Patient is hospitalized
- Patient is a woman who is less than 8 weeks postpartum or is breast-feeding
- Patient intends to move or vacation away during the study
- Patient has had any major surgery within 4 weeks of study start
- Patient is a current or past abuser of alcohol or illicit drugs
- Patient has been treated in an emergency room for asthma in the past month
- Patient had an upper respiratory infection with in 3 weeks prior to study start
- Patient has any active pulmonary disorder other than asthma
Key Trial Info
Start Date :
September 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 1999
Estimated Enrollment :
907 Patients enrolled
Trial Details
Trial ID
NCT00963599
Start Date
September 1 1999
End Date
November 1 1999
Last Update
February 9 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.